Stocks and Investing
Stocks and Investing
Thu, March 30, 2023
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
Ed Arce Reiterated (ARCT) at Hold and Held Target at $19 on, Mar 29th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Arcturus Therapeutics Holdings Inc." (ARCT) at Hold and Held Target at $19 on, Mar 29th, 2023.
Ed, nor any peers, have made any analyst calls on ARCT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources